|
AAP |
American Academy of Pediatrics |
|
ACR |
American College of Rheumatology |
|
AOSD |
Adult-onset Still’s disease |
|
CD |
Cluster of Differentiation |
|
CPG |
Clinical Practice Guideline |
|
CPS |
Canadian Pediatric Society |
|
DMARDs |
Disease-modifying antirheumatic drugs |
|
cDMARDs |
Conventional Disease-modifying antirheumatic drugs |
|
EPG |
Egyptian Pediatric Clinical Practice Guidelines Committee |
|
EULAR |
European League against Rheumatism |
|
GAG |
Guideline Adaptation Group |
|
GIN |
Guidelines International Network |
|
GKJR |
German Society for Pediatric Rheumatology |
|
GRADE |
Grading of Recommendations, Assessment, Development and Evaluation |
|
ILAR |
International League of Associations for Rheumatology |
|
IVIG |
Intravenous Immunoglobulin |
|
JADAS |
Juvenile Arthritis Disease Activity Score |
|
JAK |
Janus kinase |
|
MAS |
Macrophage activation syndrome |
|
MOH |
Ministry of Health |
|
MRI |
Magnetic Resonance Imaging |
|
mSMS |
Modified systemic manifestation score |
|
NICE |
National Institute for Health and Care Excellence |
|
NK |
Natural Killer |
|
PET-CT |
Positron Emission Tomography |
|
PRINTO |
Pediatric Rheumatology International Trials Organization |
|
QoE |
Quality of Evidence |
|
SIGN |
The Scottish Intercollegiate Guidelines Network |
|
sJIA |
Systemic Juvenile Idiopathic Arthritis |
|
SoR |
Strength of Recommendations |